Sleep quality and facial pain in fibromyalgia syndrome

Pimentel, Marcele Jardim; Gui, Maísa Soares; Reimão, Rubens; Rizzatti-Barbosa, Célia Marisa

doi:10.1179/2151090314y.0000000014

Cited by 9 publications

(3 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pain negatively influences everyday life and activities, alters behavioral profiles, impairs sleeping patterns, and diminishes quality of life and functional capabilities (Blake et al, ; Tonial et al, ). These observations have been confirmed by previous studies on selected samples of individuals (Houlihan et al, ; Liedberg, Björk, & Börsbo, ; Pimentel, Gui, Reimão, & Rizzatti‐Barbosa, ). Prevalence of CP in the general pediatric population widely ranges between 10–35% in several studies depending on age, sex, and body district involved (King et al, ; Perquin et al, ).…”

Section: Discussionsupporting

confidence: 83%

Pain in individuals with RASopathies: Prevalence and clinical characterization in a sample of 80 affected patients

Leoni

Vollono

Onesimo

et al. 2019

American J of Med Genetics Pt A

View full text Add to dashboard Cite

Pain in individuals with RASopathies is a neglected topic in literature. In this article, we assessed prevalence and profile of pain in a sample of 80 individuals affected by RASopathies. The study sample included individuals with Noonan syndrome (N = 42), Costello syndrome (N = 17), and cardio-facio-cutaneous syndrome (N = 21). A set of standardized questionnaires and scales were administered (VAS/numeric scale, r-FLACC, Wang-Baker scale, NPSI, BPI, NCCPC-R) to detect and characterize acute and chronic pain and to study the influence of pain on quality of life (PEDs-QL, SF-36) and sleeping patterns (SDSC); revision of past medical history and multisystemic evaluation was provided. Available clinical data were correlated to the presence of pain. High prevalence of acute (44%) and chronic (61%) pain was documented in the examined sample. Due to age and intellectual disability, acute pain was localized in 18/35 individuals and chronic pain in 33/49. Muscleskeletal and abdominal pain was more frequently reported. The intensity of acute and chronic pain interfered with daily activities in 1/3 of the sample. Pain negatively impacted on QoL and sleeping patterns. This work documents that pain is highly prevalent in RASopathies. Future studies including subjective and objective measures of pain are required to discriminate a somatosensory abnormality from an abnormal elaboration of painful stimuli at a central level. K E Y W O R D S cardiofaciocutaneous syndrome, costello syndrome, Noonan syndrome, pain, RASopathies

show abstract

Section: Discussionsupporting

confidence: 83%

Pain in individuals with RASopathies: Prevalence and clinical characterization in a sample of 80 affected patients

Leoni

Vollono

Onesimo

et al. 2019

American J of Med Genetics Pt A

View full text Add to dashboard Cite

show abstract

“…Using the PSQI, one study has reported that about 93% of the cases with FM experienced a poor quality of sleep, which was strongly associated with the severity of FM symptoms (Andrade et al, 2020). This high prevalence of poor sleep quality (~90%) has been also shown in previous studies (Bennett et al, 2007; Jacobson et al, 2015; Mork & Nilsen, 2012; Pimentel et al, 2015). With the prevalence rate of 90.57%, the results of this study supports the previous outcomes.…”

Section: Discussionsupporting

confidence: 81%

The frequency of psychiatric disorder co‐morbidities in patients with fibromyalgia: A cross‐sectional study in Iran

et al. 2023

View full text Add to dashboard Cite

Aim This study aimed to investigate psychiatric disorders in Iranian female patients with fibromyalgia (FM). Design Female patients, newly diagnosed with FM, were interviewed by a psychiatrist for psychiatric assessments during a 2‐year period. Methods The diagnosis of the psychiatric disorders was based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM‐5), and sleep quality was evaluated using the Pittsburgh Sleep Quality Index (PSQI). Results In total, 159 patients with the mean age of 42.15 ± 9.89 were recruited in this study. Over 92% of the cases were also diagnosed with at least one type of psychiatric disorder. Sleep disorders (SDs, 90.57%), mood disorders (MDs, 52.83%), personality disorders (PDs, 40.25%) and anxiety disorders (ADs, 16.98%) were the most prevalent diagnoses among these patients. The logistic regression results correspondingly showed that suffering from Cluster‐B PDs was associated with a higher prevalence rate of somatic symptom disorders (SSDs), with a p‐value of 0.019 and an odds ratio (OR) of 2.7.

show abstract

“…Impaired sleep quality is a common problem in the patients with FM (7,8). Prior studies have reported difficulty in falling a sleep, night-time awakenings, waking up too early in the mornings, and tiredness in the mornings despite sleeping during the night among the patients with FM (7,9).…”

Section: Introductionmentioning

confidence: 99%

Sleep quality in fibromyalgia patients and its association with disease severity, pain, depression and fatigue

Garip¹,

Öztaş²,

Güler³

et al. 2017

Eur J Ther

View full text Add to dashboard Cite

show abstract

Sleep quality and facial pain in fibromyalgia syndrome

Abstract: Fibromyalgia patients experience intense facial pain in addition to poor sleep and high disabilities. TMD and FMS association do not appear to worsen this condition; however, facial pain intensity was correlated with low sleep quality.

Cited by 9 publications

References 28 publications

Pain in individuals with RASopathies: Prevalence and clinical characterization in a sample of 80 affected patients

Pain in individuals with RASopathies: Prevalence and clinical characterization in a sample of 80 affected patients

The frequency of psychiatric disorder co‐morbidities in patients with fibromyalgia: A cross‐sectional study in Iran

Sleep quality in fibromyalgia patients and its association with disease severity, pain, depression and fatigue

Contact Info

Product

Resources

About